Clinical Trial Update: Study to Evaluate the Effectiveness of Risankizumab in Participants With a Recent Diagnosis of Moderate Plaque Psoriasis in a Real-life Setting in Greece

View source ↗

Summary

A real-world study in Greece evaluating the effectiveness of risankizumab in participants with moderate plaque psoriasis. The study status is ACTIVE_NOT_RECRUIT…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• SKYRIZI (risankizumab-rzaa)

Snippet

Sponsor: AbbVie | Conditions: Moderate Plaque Psoriasis, Moderate Psoriasis | Status: ACTIVE_NOT_RECRUITING